Jakob Haider

Jakob Haider

Auto-generated profile, based on publicly available information

Jakob Haider

Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2025 in Science
Verified
Journal Article
Closed access
SGSven Groessl
Sven Groessl
RKRobert Kalis
Robert Kalis
MSMarteinn T. Snaebjornsson
Marteinn T. Snaebjornsson
LWLeon Wambach
Leon Wambach
JHJakob Haider
Jakob Haider
JZJohannes Zuber
Johannes Zuber
Malignant tumors are characterized by diverse metabolic stresses, including nutrient shortages, hypoxia, and buildup of metabolic by-products. To understand how cancer cells adapt to such challenges, we conducted sequential CRISPR screens to identify genes that affect cellular fitness under specific metabolic stress conditions in cell culture and to then probe their relevance in pancreatic tumors. Comparative analyses of hundreds of fitness genes revealed that cancer metabolism in vivo was shaped by bioenergetic adaptations to tumor acidosis. Mechanistically, acidosis suppressed cytoplasmic activity of extracellular signal–regulated kinase (ERK), thereby preventing oncogene-induced mitochondrial fragmentation and promoting fused mitochondria. The resulting boost in mitochondrial respiration supported cancer cell adaptations to various metabolic stresses. Thus, acidosis is an environmental factor that alters energy metabolism to promote stress resilience in cancer.

14 August 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
RSRita Silvério-Alves
Rita Silvério-Alves
IKIlia Kurochkin
Ilia Kurochkin
ARAnna Rydström
Anna Rydström
CECamila Vazquez Echegaray
Camila Vazquez Echegaray
JHJakob Haider
Jakob Haider
CPCarlos-Filipe Pereira
Carlos-Filipe Pereira
In mitosis, most transcription factors detach from chromatin, but some are retained and bookmark genomic sites. Mitotic bookmarking has been implicated in lineage inheritance, pluripotency and reprogramming. However, the biological significance of this mechanism in vivo remains unclear. Here, we address mitotic retention of the hemogenic factors GATA2, GFI1B and FOS during haematopoietic specification. We show that GATA2 remains bound to chromatin throughout mitosis, in contrast to GFI1B and FOS, via C-terminal zinc finger-mediated DNA binding. GATA2 bookmarks a subset of its interphase targets that are co-enriched for RUNX1 and other regulators of definitive haematopoiesis. Remarkably, homozygous mice harbouring the cyclin B1 mitosis degradation domain upstream Gata2 partially phenocopy knockout mice. Degradation of GATA2 at mitotic exit abolishes definitive haematopoiesis at aorta-gonad-mesonephros, placenta and foetal liver, but does not impair yolk sac haematopoiesis. Our findings implicate GATA2-mediated mitotic bookmarking as critical for definitive haematopoiesis and highlight a dependency on bookmarkers for lineage commitment.